Cecilia Morgan

1.8k total citations
31 papers, 920 citations indexed

About

Cecilia Morgan is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Cecilia Morgan has authored 31 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 13 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Cecilia Morgan's work include HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (9 papers) and Immune Cell Function and Interaction (7 papers). Cecilia Morgan is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (9 papers) and Immune Cell Function and Interaction (7 papers). Cecilia Morgan collaborates with scholars based in United States, South Africa and Puerto Rico. Cecilia Morgan's co-authors include Sheila A. Lukehart, Wesley C. Van Voorhis, M. Juliana McElrath, Ann Duerr, Stephen C. De Rosa, Barbara J. Molini, Barney S. Graham, Georgia D. Tomaras, E.-J. Finke and Roland Grunow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Cecilia Morgan

31 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilia Morgan United States 16 296 259 258 255 250 31 920
Christopher Carne United Kingdom 14 157 0.5× 431 1.7× 346 1.3× 371 1.5× 539 2.2× 27 1.2k
Nonhlanhla N. Mkhize South Africa 15 152 0.5× 248 1.0× 277 1.1× 243 1.0× 281 1.1× 35 883
David C. Wright United States 10 153 0.5× 374 1.4× 248 1.0× 269 1.1× 448 1.8× 15 985
Claudiu Bandea United States 19 144 0.5× 358 1.4× 182 0.7× 395 1.5× 384 1.5× 34 1.2k
Gengfeng Fu China 19 122 0.4× 523 2.0× 72 0.3× 662 2.6× 290 1.2× 91 1.2k
Wes Rountree United States 14 141 0.5× 262 1.0× 201 0.8× 424 1.7× 303 1.2× 38 907
Jason Neidleman United States 18 418 1.4× 206 0.8× 604 2.3× 519 2.0× 628 2.5× 34 1.3k
Sean Philpott United States 18 181 0.6× 208 0.8× 350 1.4× 667 2.6× 739 3.0× 39 1.3k
David Yirrell United Kingdom 22 191 0.6× 521 2.0× 235 0.9× 734 2.9× 1.0k 4.2× 63 1.5k
Marein A.W.P. de Jong Netherlands 16 301 1.0× 324 1.3× 819 3.2× 240 0.9× 373 1.5× 18 1.4k

Countries citing papers authored by Cecilia Morgan

Since Specialization
Citations

This map shows the geographic impact of Cecilia Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Morgan more than expected).

Fields of papers citing papers by Cecilia Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Morgan. The network helps show where Cecilia Morgan may publish in the future.

Co-authorship network of co-authors of Cecilia Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Morgan. A scholar is included among the top collaborators of Cecilia Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Morgan. Cecilia Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curlin, Marcel E., Jason Shao, Gabriela Diaz, et al.. (2020). Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine. Vaccine. 38(36). 5814–5821. 2 indexed citations
2.
Dietrich, Janan, Stefanie Hornschuh, Kennedy Otwombe, et al.. (2020). A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa. PLoS ONE. 15(4). e0231086–e0231086. 10 indexed citations
3.
Lazarus, Erica, Kennedy Otwombe, Janan Dietrich, et al.. (2019). Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa. Southern African Journal of HIV Medicine. 20(1). 866–866. 2 indexed citations
4.
Liu, Feng‐Liang, Qingli Niu, Wei Hou, et al.. (2018). Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathogens. 14(2). e1006888–e1006888. 25 indexed citations
5.
Dietrich, Janan, Erica Lazarus, Michele Andrasik, et al.. (2018). Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa. AIDS and Behavior. 22(7). 2312–2321. 18 indexed citations
6.
Richert, Laura, Zoe Moodie, Chloé Pasin, et al.. (2016). Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy. PLoS ONE. 11(4). e0152952–e0152952. 2 indexed citations
7.
Hayes, Peter, Josephine H. Cox, Natalia Fernández, et al.. (2016). Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition. AIDS. 30(11). 1703–1712. 15 indexed citations
8.
Jin, Xia, Cecilia Morgan, Xuesong Yu, et al.. (2015). Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials. Vaccine. 33(20). 2347–2353. 26 indexed citations
9.
Deschamps, Marie, Barbara Metch, Cecilia Morgan, et al.. (2015). Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(1). 70–77. 14 indexed citations
10.
Sachdev, Darpun, Hasan Ahmed, Yunda Huang, et al.. (2014). Sex Differences in Immune Variables in the RV144 Trial. AIDS Research and Human Retroviruses. 30(S1). A191–A191. 1 indexed citations
11.
Deschamps, Marie, Carmen Zorrilla, Cecilia Morgan, et al.. (2013). Recruitment of Caribbean female commercial sex workers at high risk of HIV infection.. PubMed. 34(2). 92–8. 16 indexed citations
12.
Koblin, Beryl A., Barbara Metch, Richard Novák, et al.. (2013). Feasibility of Identifying a Cohort of US Women at High Risk for HIV Infection for HIV Vaccine Efficacy Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(2). 239–244. 12 indexed citations
13.
Metch, Barbara, Ian Frank, Richard M. Novak, et al.. (2012). Recruitment of Urban US Women at Risk for HIV Infection and Willingness to Participate in Future HIV Vaccine Trials. AIDS and Behavior. 17(2). 760–772. 11 indexed citations
14.
Kublin, James G., Cecilia Morgan, Peter B. Gilbert, et al.. (2012). HIV Vaccine Trials Network: activities and achievements of the first decade and beyond. Clinical Investigation. 2(3). 245–254. 12 indexed citations
15.
Koblin, Beryl A., Martín Casapía, Cecilia Morgan, et al.. (2011). Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial. PLoS ONE. 6(9). e24517–e24517. 33 indexed citations
16.
Rosa, Stephen C. De, Evan P. Thomas, John Bui, et al.. (2011). HIV-DNA Priming Alters T Cell Responses to HIV-Adenovirus Vaccine Even When Responses to DNA Are Undetectable. The Journal of Immunology. 187(6). 3391–3401. 40 indexed citations
17.
Peiperl, Larry, Cecilia Morgan, Zoe Moodie, et al.. (2010). Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054). PLoS ONE. 5(10). e13579–e13579. 38 indexed citations
18.
Cheng, Cheng, Jason G. Gall, Martha Nason, et al.. (2009). Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization. Journal of Virology. 84(1). 630–638. 57 indexed citations
19.
Morgan, Cecilia, Marta L. Marthas, Christopher J. Miller, et al.. (2008). The Use of Nonhuman Primate Models in HIV Vaccine Development. PLoS Medicine. 5(8). e173–e173. 79 indexed citations
20.
Chanteau, S, Lila Rahalison, M. Ratsitorahina, et al.. (2000). Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick. International Journal of Medical Microbiology. 290(3). 279–283. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026